Psychological Distress as a Negative Survival Factor for Patients with Hematologic Malignancies Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation

被引:12
|
作者
Park, Ji Eun [1 ]
Kim, Kyung Im [1 ]
Yoon, Sung Soo [2 ]
Hahm, Bong Jin [3 ]
Lee, Sang Min [1 ]
Yoon, Jeong Hyun [5 ]
Shin, Wan Gyoon [1 ]
Lee, Hye Suk [4 ]
Oh, Jung Mi [1 ]
机构
[1] Seoul Natl Univ, Dept Clin Pharm, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea
[4] Seoul Natl Univ Hosp, Dept Pharm, Seoul 110744, South Korea
[5] Pusan Natl Univ, Dept Clin Pharm, Coll Pharm, Pusan 609735, South Korea
来源
PHARMACOTHERAPY | 2010年 / 30卷 / 12期
关键词
psychological stress; distress; hematopoietic stem cell transplantation; hematologic malignancy; survival; BONE-MARROW-TRANSPLANTATION; UMBILICAL-CORD BLOOD; ACUTE MYELOID-LEUKEMIA; SYMPTOM DISTRESS; RISK-FACTOR; DEPRESSION; MORTALITY; IMPACT; ADULTS; ASSOCIATION;
D O I
10.1592/phco.30.12.1239
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective To evaluate the influence of distress on overall survival of patients with hematologic malignancies who underwent allogeneic stem cell transplantation (allo-SCT) and to analyze the possible risk factors for death Design Retrospective cohort study Setting Large tertiary care teaching hospital Patients Seventy-seven patients (aged >= 15 yrs) with hematologic malignancies who underwent allo-SCT between January 2000 and August 2007, 20 patients with distress history were matched in a 1 3 ratio with 57 patients without distress history Measurements and Main Results The primary outcome was overall survival, defined as the time from allo-SCT to disease-related death or last date of follow-up Secondary outcomes were time to hematologic recovery (absolute neutrophil count >= 500 cells/mm(3)) from day of allo-SCT, length of hospital stay, and opioid usage Sociodemographic information and clinical characteristics were analyzed for possible risk factors Patient history of psychological distress resulted in a significantly higher mortality rate in the first year after allo-SCT (hazard ratio [HR] 3 05, 95% confidence interval [CI] 1 48-6 28, p=0 001) and led to a shorter overall survival rate (HR 1 63, 95% CI 0 86-3 10 p=0 133) However, psychological distress had no effect on hospital length of stay, hematologic recovery time, opioid usage status, or dose of opioid analgesics used Factors associated with death after allo-SCT in the univariate analysis (p<0 05) were high-relapse risk disease, umbilical cord blood SCT, total-body irradiation-containing conditioning regimen, and higher educational background In the multivariate analysis, high relapse risk (HR 3 85, 95% CI 1 81-8 20, p<0 001) and total-body irradiation-containing conditioning regimen (HR 3 50, 95% CI 1 29-9 51, p=0 01) were identified as risk factors for death Conclusion A history of psychological distress before allo-SCT, after adjusting for other patient- and disease-related prognostic factors, had a significant influence on early death in the first year after transplantation
引用
收藏
页码:1239 / 1246
页数:8
相关论文
共 50 条
  • [21] Subsequent malignancies after allogeneic hematopoietic stem cell transplantation
    Gunduz, Mehmet
    Ozen, Mehmet
    Sahin, Ugur
    Toprak, Selami Kocak
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Beksac, Meral
    Ilhan, Osman
    Gurman, Gunhan
    Topcuoglu, Pervin
    CLINICAL TRANSPLANTATION, 2017, 31 (07)
  • [22] Factors Influencing Outcome and Incidence of Late Complications in Children who Underwent Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathy
    Khalil, Abdalla
    Zaidman, Irena
    Elhasid, Ronit
    Peretz-Nahum, Monique
    Futerman, Boris
    Ben-Arush, Myriam
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2012, 29 (08) : 694 - 703
  • [23] Modified Busulfan and Cyclophosphamide Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Patients With Hematologic Malignancies
    Zhao, X. F.
    Mao, X. F.
    Wan, D. M.
    Liu, W.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1531 - 1535
  • [24] Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning
    Casper, Jochen
    Wolff, Daniel
    Knauf, Wolfgang
    Blau, Igor W.
    Ruutu, Tapani
    Volin, Liisa
    Wandt, Hannes
    Schaefer-Eckart, Kerstin
    Holowiecki, Jerzy
    Giebel, Sebastian
    Aschan, Johan
    Zander, Axel R.
    Kroeger, Nicolaus
    Hilgendorf, Inken
    Baumgart, Joachim
    Mylius, Heidrun A.
    Pichlmeier, Uwe
    Freund, Mathias
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3344 - 3351
  • [25] Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
    Sevcikova, Aneta
    Fridrichova, Ivana
    Nikolaieva, Nataliia
    Kalinkova, Lenka
    Omelka, Radoslav
    Martiniakova, Monika
    Ciernikova, Sona
    CANCERS, 2023, 15 (09)
  • [26] Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies
    Mulanovich, Victor E.
    Desai, Parth A.
    Popat, Uday R.
    AIDS, 2016, 30 (17) : 2653 - 2657
  • [27] Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies
    Xiao, Haowen
    Luo, Yi
    Lai, Xiaoyu
    Fu, Shan
    Shi, Jimin
    Tan, Yamin
    He, Jingsong
    Xie, Wanzhuo
    Zheng, Weiyan
    Wang, Li-Mengmeng
    Zhang, Lifei
    Liu, Lizhen
    Ye, Xiujin
    Yu, Xiaohong
    Cai, Zhen
    Lin, Maofang
    Huang, He
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (12): : 1804 - 1812
  • [28] Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
    Arrieta-Bolanos, Esteban
    Bonneville, Edouard F.
    Crivello, Pietro
    Robin, Marie
    Gedde-Dahl, Tobias
    Salmenniemi, Urpu
    Kroeger, Nicolaus
    Yakoub-Agha, Ibrahim
    Crawley, Charles
    Choi, Goda
    Broers, Annoek E. C.
    Forcade, Edouard
    Carre, Martin
    Poire, Xavier
    Huynh, Anne
    Lenhoff, Stig
    Ciceri, Fabio
    Tholouli, Eleni
    Schroeder, Thomas
    Deconinck, Eric
    Carlson, Kristina
    de Wreede, Liesbeth C.
    Hoogenboom, Jorinde D.
    Malard, Florent
    Ruggeri, Annalisa
    Fleischhauer, Katharina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [29] Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies
    Green, Margaret L.
    CLINICS IN CHEST MEDICINE, 2017, 38 (02) : 295 - +
  • [30] Clinical observation of patients with hematologic malignancies treated with hematopoietic stem cell transplantation
    Zhang Donghua
    Zhang Lu
    Xiao Yi
    Huang Wei
    Li Dengju
    Ran Dan
    Huang Liang
    Zhou Jianfeng
    Huang Mei
    Sun Hanying
    Liu Wenli
    Current Medical Science, 2004, 24 (4) : 345 - 349